Skip to search formSkip to main contentSkip to account menu

lamifiban

Known as: ((1-(N-(p-(amidinobenzoyl)tyrosyl)-4-piperidinyl)oxy))acetic acid 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (5)

AcetatesAcetic Acid EstersAnticoagulantsPlatelet Aggregation Inhibitors
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Mecanismos de acción de los diferentes agentes antiplaquetarios
Review
2011
Review
2011
Optimal Use of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Patients Undergoing Percutaneous Coronary Interventions
Discovery of the central role of platelets in the pathogenesis of acute coronary syndromes (ACS) and ischaemic complications of… 
2005
2005
Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials).
2002
2002
Lack of effect of glycoprotein IIb/IIIa blockade on myocardial platelet or polymorphonuclear leukocyte accumulation and on infarct size after transient coronary occlusion in pigs.
2001
2001
Differential antiplatelet effects of various glycoprotein IIb-IIIa antagonists.
Review
2001
Review
2001
Platelet glycoprotein IIb/IIIa-receptor inhibitors in patients with acute coronary syndromes or undergoing percutaneous coronary interventions: a review.
2001
2001
Comparative specificity of platelet alpha(IIb)beta(3) integrin antagonists.
Several platelet alpha(IIb)beta(3) integrin antagonists have been designed as preventive agents against the formation of arterial… 
1999
1999
Lamifiban. Point of view
Lamifiban is an intravenously administered, selective, reversible, nonpeptide glycoprotein IIb/IIIa receptor antagonist which… 
1999
1999
New antithrombotic treatment in unstable coronary syndrome—for whom?
1997
1997
Interaction of a thrombin inhibitor and a platelet GP IIb/IIIa antagonist in vivo: evidence that thrombin mediates platelet aggregation and subsequent thromboxane A2 formation during coronary…
We examined the effect of a specific thrombin inhibitor, Ro 46-6240, alone and combined with an antagonist of the platelet GP IIb… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)